Found: 18
Select item for more details and to access through your institution.
Reply.
- Published in:
- 2017
- By:
- Publication type:
- letter
Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1001025
- By:
- Publication type:
- Article
Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
- Published in:
- Rheumatology, 2015, v. 54, n. 12, p. 2239, doi. 10.1093/rheumatology/kev251
- By:
- Publication type:
- Article
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making.
- Published in:
- Patient, 2020, v. 13, n. 1, p. 57, doi. 10.1007/s40271-019-00381-y
- By:
- Publication type:
- Article
Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2022, p. 1, doi. 10.1177/1759720X221114105
- By:
- Publication type:
- Article
What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study).
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 2, p. 589, doi. 10.1007/s40744-021-00423-8
- By:
- Publication type:
- Article
Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 3, p. 1435, doi. 10.1007/s40744-021-00332-w
- By:
- Publication type:
- Article
Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 4, p. 473, doi. 10.1007/s40744-019-00178-3
- By:
- Publication type:
- Article
Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1032-z
- By:
- Publication type:
- Article
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain.
- Published in:
- ClinicoEconomics & Outcomes Research, 2019, v. 11, p. 395, doi. 10.2147/CEOR.S201621
- By:
- Publication type:
- Article
Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 7, p. 2665, doi. 10.1007/s10067-021-05603-z
- By:
- Publication type:
- Article
Anti-citrullinated peptide/protein antibodies in Palindromic rheumatism: comment on the article by Emad Y et al.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2020, p. 1, doi. 10.1177/1759720X20978139
- By:
- Publication type:
- Article
Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1764-z
- By:
- Publication type:
- Article
Differing specificities and isotypes of anticitrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1329-6
- By:
- Publication type:
- Article